HMGB1 and cancer: The overexpression of HMGB1 has been confirmed in a variety of cancers, such as prostate cancer15, renal cell carcinoma16, bladder cancer17, hepatocellular carcinoma18, gastric cancer19, colorectal cancer20, and lung cancer21.